Salt the day away in these treatment caves. Photo courtesy of The Salt Suite

Locals suffering from the assault of our city’s many allergens, or from lung or skin afflictions, may soon find relief thanks to one of the most common compounds on the planet: salt.

Halotherapy, a treatment in which users breathe in tiny salt particles that dates back to the 12th century, will be available later this year in Houston thanks to The Salt Suite, the nation’s only salt therapy franchise chain.

The company has announced plans to open 20 new locations in Houston by the end of 2022. Areas that The Salt Suite is targeting include River Oaks, Galleria/Uptown, West Memorial, I-10 Villages, and Katy, a company spokesperson tells CultureMap.

How does it work? Through 45-minute salt therapy sessions in Salt Suite’s “caves,” a machine — dubbed a halogenerator — grinds pharmaceutical-grade dry salt into micro-sized particles, which are dispersed into the air of the salt rooms, per a press release. Guests are encouraged to lounge, relax, and breathe in the purified, antibacterial micro salt particles in the air.

This halotherapy, the company claims, helps allergy symptoms, respiratory ailments, skin issues, and boost the immune system. (The salt lounges are certainly cozy.) Membership plans start at $109, per the company website.

Salt Suite brass adds that the company tapped Houston for one of our more famous, or infamous, features — allergies.

“Not many people know that Houston is also one of the country’s worst allergy cities in the U.S.,” said Tiffany Dodson, CEO of The Salt Suite, in a statement, “which has us excited to bring much-needed relief to local Houston communities and introduce them to the benefits of halotherapy.”

Other Salt Suite options include children’s sessions, skin care, salt booths, and private events.

Those interested in salt sessions or even franchise opportunities can find information online.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston femtech co. debuts new lactation and wellness pods

mom pod

Houston-based femtech company Work&, previously known as Work&Mother, has introduced new products in recent months aimed at supporting working mothers and the overall health of all employees.

The company's new Lactation Pod and Hybrid Pod serve as dual-use lactation and wellness spaces to meet employer demand, the company shared in a news release. The compact pods offer flexible design options that can serve permanent offices and nearly all commercial spaces.

They feature a fully compliant lactation station while also offering wellness functionalities that can support meditation, mental health, telehealth and prayer. In line with Work&'s other spaces, the pods utilize the Work& scheduling platform, which prioritizes lactation bookings to help employers comply with the PUMP Act.

“This isn’t about perks,” Jules Lairson, Work& co-founder and COO, said in the release. “It’s about meeting people where they are—with dignity and intentional design. That includes the mother returning to work, the employee managing anxiety, and everyone in between.”

According to the company, several Fortune 500 companies are already using the pods, and Work& has plans to grow the products' reach.

Earlier this year, Work& introduced its first employee wellness space at MetroNational’s Memorial City Plazas, representing Work&'s shift to offer an array of holistic health and wellness solutions for landlords and tenants.

The company, founded in 2017 by Lairson and CEO Abbey Donnell, was initially focused on outfitting commercial buildings with lactation accommodations for working parents. While Work& still offers these services through its Work&Mother branch, the addition of its Work&Wellbeing arm allowed the company to also address the broader wellness needs of all employees.

The company rebranded as Work& earlier this year.

Rice biotech studio secures investment from Modi Ventures, adds founder to board

fresh funding

RBL LLC, which supports commercialization for ventures formed at the Rice University Biotech Launch Pad, has secured an investment from Houston-based Modi Ventures.

Additionally, RBL announced that it has named Sahir Ali, founder and general partner of Modi Ventures, to its board of directors.

Modi Ventures invests in biotech companies that are working to advance diagnostics, engineered therapeutics and AI-driven drug discovery. The firm has $134 million under management after closing an oversubscribed round this summer.

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. William McKeon, president and CEO of the TMC, previously called the launch of RBL a “critical step forward” for Houston’s life sciences ecosystem.

“RBL is dedicated to building companies focused on pioneering and intelligent bioelectronic therapeutics,” Ali said in a LinkedIn post. “This partnership strengthens the Houston biotech ecosystem and accelerates the transition of groundbreaking lab discoveries into impactful therapies.”

Ali will join board members like managing partner Paul Wotton, Rice bioengineering professor Omid Veiseh, scientist and partner at KdT Ventures Rima Chakrabarti, Rice alum John Jaggers, CEO of Arbor Biotechnologies Devyn Smith, and veteran executive in the life sciences sector James Watson.

Ali has led transformative work and built companies across AI, cloud computing and precision medicine. Ali also serves on the board of directors of the Drug Information Association, which helps to collaborate in drug, device and diagnostics developments.

“This investment by Modi Ventures will be instrumental to RBL’s growth as it reinforces confidence in our venture creation model and accelerates our ability to develop successful biotech startups,” Wotton said in the announcement. "Sahir’s addition to the board will also amplify this collaboration with Modi. His strategic counsel and deep understanding of field-defining technologies will be invaluable as we continue to grow and deliver on our mission.”